Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AMLNicholas J. Short, Farhad Ravandi, Musa Yılmaz et al.|Journal of Clinical Oncology|2024Cited by 161
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALLHagop M. Kantarjian, Elias Jabbour, Nicholas J. Short et al.|Journal of Clinical Oncology|2024Cited by 81
Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II TrialFadi Haddad, Hagop M. Kantarjian, Elias Jabbour et al.|Blood|2023Cited by 11